This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of sequencing technology and associated services to support research initiatives. The $20,210 firm fixed price purchase order, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh, does not have a set-aside designation. Oxford Nanopore Technologies holds additional federal contract vehicles, including a $300,000 blanket purchase...
This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
This is a federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency. The contract is for the delivery of laboratory equipment, specifically next-generation genomic sequencing devices, consumables, and associated services. The contract has no set-aside designation and is a firm fixed-price purchase order with a ceiling value of $68,067.00. The award...
Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was awarded a $9,350 firm fixed-price purchase order (Contract ID 75D30123P15957) by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, for equipment software licenses and warranties. The contract has an ultimate completion date of April 30, 2023 and does not utilize a set-aside. This award is part of Oxford Nanopore's broader portfolio of federal contracts, which include...
This federal contract award, valued at $12,500.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a GridION software license and device warranty. Oxford Nanopore Technologies specializes in nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins, and has secured numerous federal contracts to supply next-generation...
The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
This federal contract award is for the delivery of lab supplies for COVID-19 detection, with an award value of $16,255.00, to the Centers for Disease Control and Prevention (CDC) Pittsburgh field office. The contract was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company that develops and provides nanopore-based electronic systems for molecular analysis. The contract is a firm-fixed-price purchase order with a completion date of November 15, 2021, and...
This firm fixed-price purchase order, valued at $16,199.00, was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides for the delivery of Oxford Nanopore's VOLTRAX V2 CAPEX equipment, which is part of their nanopore-based electronic systems used for real-time analysis of genetic materials and other biological molecules. The contract has no set-aside designation. Oxford Nanopore...